A new investigational oral treatment option may help you balance your Lupus Nephritis and Immunoglobulin A Nephropathy symptoms.
See if you may qualify
The RestoreD Study is a clinical research study evaluating an oral investigational medication, ALXN2050, that may help participants manage their Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) symptoms.
To learn more and to see if you may qualify, talk to your doctor or click the link below.
Learn more about the RestoreD Study.
Reimbursement for travel may be available.